Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

Columbia physicist Isidor Isaac Rabi discovered nuclear magnetic resonance in the 1930s. Today, it lets doctors look inside ...

When you think of routine health checkups, blood pressure screenings and cholesterol tests probably come to mind. Perhaps not MRIs. But they've been making headlines lately, with everyone from ...

A joint research team led by Professors Jaesok Yu, Hoejoon Kim, and Sanghoon Lee of the Department of Robotics and ...

Preparing to play in his 161st consecutive game Sunday, Byard remains on a mission to squeeze the most from his NFL career.

Tukysa added to Herceptin and Perjeta improved progression-free survival versus placebo in HER2-positive metastatic breast ...

Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance ...

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with ...

A new study published in JAMA Network Open highlights the significant environmental footprint of medical imaging contrast ...

Guideline states that prochlorperazine IV and greater occipital nerve blocks must be offered to eligible adults requiring parenteral therapy.